New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering glucose levels and body weight.At the Cardiometabolic Health Congress in ...
Starting later this year, Ouro intends to start a phase 1 clinical trial of its own, eyeing the development of the drug for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback